1. Academic Validation
  2. Synthesis and opioid activity of enantiomeric N-substituted 2,3,4,4a,5,6,7,7a-octahydro-1H-benzofuro[3,2-e]isoquinolines

Synthesis and opioid activity of enantiomeric N-substituted 2,3,4,4a,5,6,7,7a-octahydro-1H-benzofuro[3,2-e]isoquinolines

  • J Med Chem. 2010 Feb 11;53(3):1392-6. doi: 10.1021/jm901503e.
Ling-Wei Hsin 1 Li-Te Chang Richard B Rothman Christina M Dersch James A Fishback Rae R Matsumoto
Affiliations

Affiliation

  • 1 School of Pharmacy, College of Medicine, National Taiwan University, Number 1, Jen-Ai Road, Taipei, Taiwan 10018, ROC. [email protected]
Abstract

A series of enantiomeric N-substituted 2,3,4,4a,5,6,7,7a-octahydro-1H-benzofuro[3,2-e]isoquinolines was synthesized. The (-)-enantiomers had much greater kappa-, mu-, and delta-opioid receptor binding affinity than the corresponding (+)-enantiomers. Compounds (-)-1a, (-)-1b, and (-)-1c displayed subnanomolar binding affinity for the mu-receptor, and (-)-1b had a high affinity for the kappa-receptor. Compound (-)-1a was a mu-partial agonist and kappa-antagonist. Compound (-)-1b was a potent neutral mu-antagonist (K(d) = 0.22 nM) and a kappa-partial agonist.

Figures